HBV-induced liver cirrhosis patients exhibit elevated levels of S100A8/A9, natural killer (NK) cells, and interferon-gamma (IFN-γ) following STAT3 activation, a biomarker profile associated with diabetes development (Li et al., 2024). Here, IFNG is linked to cirrhosis of liver.